2019
DOI: 10.1016/j.amj.2019.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Intravenous Versus Intraosseous Access in Prehospital Cardiac Arrest

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 10 publications
2
9
0
Order By: Relevance
“…4, 5). These observations are consistent with reports of significantly reduced ROSC rates among initial nonshockable, cardiac arrest victims treated via intraosseous access versus IV access 23 …”
Section: Discussionsupporting
confidence: 91%
“…4, 5). These observations are consistent with reports of significantly reduced ROSC rates among initial nonshockable, cardiac arrest victims treated via intraosseous access versus IV access 23 …”
Section: Discussionsupporting
confidence: 91%
“…Our results also indicated that an IV route should also be established quickly for OHCA patients who have received a first-attempt and successful prehospital IO access. Additionally, our results indirectly supported some currently published evidence that the IV approach appears to be the optimal route for epinephrine administration in advanced life support for OHCA during resuscitation [8][9][10][11][12][13].…”
Section: Ta B L E 3 Logistic Regression For Sustained Rosc With Oddssupporting
confidence: 87%
“…Given the relative ease and speed with which it can be achieved, a higher successful placement rate compared with IV cannulation, and the relatively low procedural risk, intraosseous (IO) access has grown in popularity and is increasingly implemented as a first-line approach for drug administration during cardiac arrest [6,7]. However, recent observational studies support the theory that IV access appears to be the optimal route for epinephrine administration during resuscitation [8][9][10][11][12]. In a 2020 study by Zhang et al [13], where the IV or IO routes of OHCA patients were the first and only attempted route, IO treatment was associated with worse outcomes in comparison to an IV approach.…”
Section: Introductionmentioning
confidence: 99%
“…16 Observational studies have had mixed outcomes, though they tend to favor intravenous over IO for ACLS drugs. [17][18][19][20] Meta-analysis of these studies favors intravenous over IO for ROSC and long-term survival after cardiac arrest. 21 In controlled swine models of cardiac arrest, time to ROSC and Pk analyses is equivalent for intravenous compared with various models of sternal and humeral IO for delivery of amiodarone, epinephrine and vasopressin.…”
Section: Discussionmentioning
confidence: 99%